Citi Pharma gets CCP Nod for Pakheim acquisition
The Competition Commission of Pakistan (CCP) has authorized the proposed acquisition of 100% shareholding of Pakheim International Pharma (Private) Limited by Citi Pharma Limited (PSX: CPHL), the pharmaceutical company has stated in a filing to the P
October 19, 2026 (MLN): The Competition Commission of Pakistan (CCP) has authorized the proposed acquisition of 100% shareholding of Pakheim International Pharma (Private) Limited by Citi Pharma Limited (PSX: CPHL), the pharmaceutical company has stated in a filing to the Pakistan Stock Exchange. The company has received the CCP’s order dated October 9, 2026, passed in Case No. 1614/Merger-CCP/2026. The authorizatio...